WKN: | 603035 |
ISIN: | US0042251084 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Acadia Pharmaceuticals-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 16. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 3,34 | 18,05 | 440,42% |
2 | 2012 | 0,82 | 3,34 | 307,32% |
3 | 2019 | 13,20 | 38,79 | 193,86% |
4 | 2023 | 14,84 | 28,20 | 90,03% |
5 | 2005 | 4,38 | 8,25 | 88,36% |
6 | 2009 | 0,57 | 0,90 | 57,89% |
7 | 2014 | 18,05 | 25,79 | 42,88% |
8 | 2025 | 16,08 | 21,30 | 32,46% |
9 | 2015 | 25,79 | 32,34 | 25,40% |
10 | 2007 | 6,65 | 7,68 | 15,49% |
11 | 2020 | 38,79 | 43,37 | 11,81% |
12 | 2011 | 0,76 | 0,82 | 7,89% |
13 | 2017 | 26,85 | 25,58 | -4,73% |
14 | 2010 | 0,90 | 0,76 | -15,56% |
15 | 2016 | 32,34 | 26,85 | -16,98% |
16 | 2006 | 8,25 | 6,65 | -19,39% |
17 | 2022 | 21,00 | 14,84 | -29,33% |
18 | 2024 | 28,20 | 16,08 | -42,98% |
19 | 2018 | 25,58 | 13,20 | -48,40% |
20 | 2021 | 43,37 | 21,00 | -51,58% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 7,68 | 0,57 | -92,58% |
2 | 2021 | 43,37 | 21,00 | -51,58% |
3 | 2018 | 25,58 | 13,20 | -48,40% |
4 | 2024 | 28,20 | 16,08 | -42,98% |
5 | 2022 | 21,00 | 14,84 | -29,33% |
6 | 2006 | 8,25 | 6,65 | -19,39% |
7 | 2016 | 32,34 | 26,85 | -16,98% |
8 | 2010 | 0,90 | 0,76 | -15,56% |
9 | 2017 | 26,85 | 25,58 | -4,73% |
10 | 2011 | 0,76 | 0,82 | 7,89% |
11 | 2020 | 38,79 | 43,37 | 11,81% |
12 | 2007 | 6,65 | 7,68 | 15,49% |
13 | 2015 | 25,79 | 32,34 | 25,40% |
14 | 2025 | 16,08 | 21,30 | 32,46% |
15 | 2014 | 18,05 | 25,79 | 42,88% |
16 | 2009 | 0,57 | 0,90 | 57,89% |
17 | 2005 | 4,38 | 8,25 | 88,36% |
18 | 2023 | 14,84 | 28,20 | 90,03% |
19 | 2019 | 13,20 | 38,79 | 193,86% |
20 | 2012 | 0,82 | 3,34 | 307,32% |